explore -WSS

explore

author：entertainment 2025-09-10 04:17:10 - browse：41338

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Solve the antibiotic resistance crisis with preventive drugs

WSS

STAT Readout Newsletter: Today's biggest biotech updates

Why you get paid to donate plasma but not blood

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

What we know about the American soldier detained in North Korea

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

15 die by electrocution after transformer explodes in northern India

focus

explore

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

FDA gives detailed accounting of AI

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Tori Bowie and the unacceptable rates of Black maternal death

A look at other Americans who have crossed into North Korea over the years

The cancer drug shortage isn’t new — and neither are the solutions

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Hollywood unions extend contract negotiations for actors

House passes resolution saying Israel isn't a 'racist or apartheid state'

Wikipedia

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Study: Hearing aids may slow cognitive decline in those at risk

Will Ozempic

House passes resolution saying Israel isn't a 'racist or apartheid state'

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Will Ozempic

leisure time

hotspot

hotspot

hotspot